The Phase III SOPHIA clinical trial is evaluating whether margetuximab (MacroGenics) plus chemotherapy has longer progression free survival and overall survival than patients treated with trastuzumab (Herceptin/Roche) plus chemotherapy. Dr. Hope S. Rugo of University...
Metastatic Breast Cancer
Category
Metastatic Breast Cancer Alliance Announces Breast Cancer Patient and Researcher Engagement & Matching Tool
The Metastatic Breast Cancer Alliance (MBCA), the largest coalition of nonprofit breast cancer organizations, pharmaceutical/biotech companies, and patient advocates in America, released MBC Connect 2.0, an interactive web-and-mobile-friendly patient registry...
UCLA’s Dr. Dennis J. Slamon & Patient Discuss the Results of MONALEESA-3 (Novartis) and Potential for Metastatic Breast Cancer Patients
An investigational breast cancer drug shows promise with the recent MONALEESA-3 results. Overall survival data in women with HR+/HER2-metastatic breast cancer according to recent presentations at the Presidential Symposium at the European Society for Medical Oncology...
Odonate Therapeutics Announces Patient Enrollment Completion for CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer
Odonate Therapeutics, Inc., a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced the completion of enrollment in CONTESSA, a multinational, multicenter,...
Metastatic Breast Cancer Conference Brings Hope and Help to Hundreds in Seattle, WA
Clinical trials took top billing at the fourth annual Northwest Metastatic Breast Cancer Conference held September 7th at the Amazon Meeting Center in Seattle. Scientists from Fred Hutchinson Cancer Research Center shared new treatments; National Cancer Institute...